Introgen Therapeutics, Inc. (INGN) Tops Q2 EPS by 4c, Raises Guidance

Go back to Introgen Therapeutics, Inc. (INGN) Tops Q2 EPS by 4c, Raises Guidance
INOGEN (NASDAQ: INGN) Delayed: 6.76 +0.22 (3.36%)
Previous Close $6.54    52 Week High $64.37 
Open $6.54    52 Week Low $28.81 
Day High $6.84    P/E N/A 
Day Low $6.54    EPS $-0.36 
Volume 211,314